Patents by Inventor Michael Ausborn

Michael Ausborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORGANIC COMPOUNDS
    Publication number: 20220273574
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: May 19, 2022
    Publication date: September 1, 2022
    Inventors: Holger PETERSEN, Olivier Jean LAMBERT, Rolf LÖFFLER, Michael AUSBORN, Jean-Daniel BONNY
  • ORGANIC COMPOUNDS
    Publication number: 20200009056
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 9, 2020
    Inventors: Holger Petersen, Olivier Jean Lambert, Rolf Löffler, Michael Ausborn, Jean-Daniel Bonny
  • Organic Compounds
    Publication number: 20170281548
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: June 20, 2017
    Publication date: October 5, 2017
    Inventors: Holger PETERSEN, Olivier Jean LAMBERT, Rolf LÖFFLER, Michael AUSBORN, Jean-Daniel BONNY
  • ORGANIC COMPOUNDS
    Publication number: 20140323415
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly(lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: July 14, 2014
    Publication date: October 30, 2014
    Inventors: Holger PETERSEN, Olivier LAMBERT, Rolf LEOFFLER, Michael Ausborn, Jean-Daniel BONNY
  • PHARMACEUTICAL MICROPARTICLES
    Publication number: 20130236550
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1)) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Application
    Filed: April 26, 2013
    Publication date: September 12, 2013
    Applicant: NOVARTIS AG
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Pharmaceutical microparticles
    Patent number: 8460709
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: June 11, 2013
    Assignee: Novartis AG
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
    Publication number: 20120269894
    Abstract: The present invention relates to ophthalmic depot formulations comprising an active agent, e.g. embedded in a pharmacologically acceptable biocompatible polymer or a lipid encapsulating agent, e.g. for periocular or subconjunctival administration.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 25, 2012
    Inventors: Marklus AHLHEIM, Michael AUSBORN, David BODMER, Christian SCHOCH
  • MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES
    Publication number: 20120214749
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Application
    Filed: April 26, 2012
    Publication date: August 23, 2012
    Applicant: NOVARTIS AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • Microparticles comprising somatostatin analogues
    Patent number: 8188037
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: May 29, 2012
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • PHARMACEUTICAL MICROPARTICLES
    Publication number: 20120107408
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 3, 2012
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Pharmaceutical microparticles
    Patent number: 8110224
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: February 7, 2012
    Assignee: Novartis AG
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20110305742
    Abstract: A device implantable into a human or animal body comprising a biodegradable polymer which comprises ethylene carbonate units of the formula A -(—C(O)—O—CH2—CH2—O—)-??A having an ethylene carbonate content of 70 to 100 Mol %, an intrinsic viscosity of 0.4 to 4.0 dl/g measured in chloroform at 20° C. at a concentration of 1 g/dl and a glass transition temperature of from 5 to 50° C., degradable by surface erosion which is governed by a non-hydrolytic mechanism.
    Type: Application
    Filed: April 20, 2011
    Publication date: December 15, 2011
    Inventors: Michael Ausborn, Thomas Kissel
  • MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES
    Publication number: 20100272809
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Application
    Filed: June 8, 2010
    Publication date: October 28, 2010
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • MICROPARTICLES PREPARED USING AN IONIC LIQUID
    Publication number: 20100239524
    Abstract: Microparticles comprising at least one active agent embedded within a biocompatible, biodegradable polymeric matrix, wherein said microparticles are prepared with an ionic liquid.
    Type: Application
    Filed: May 28, 2010
    Publication date: September 23, 2010
    Inventors: Michael Ausborn, Thomas Kissel, Ernst Küsters
  • Microparticles comprising somatostatin analogues
    Patent number: 7759308
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: July 20, 2010
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • OPHTHALMIC DEPOT FORMULATIONS FOR PERIOCULAR OR SUCONJUNCTIVAL ADMINISTRATION
    Publication number: 20080305172
    Abstract: The present invention relates to ophthalmic depot formulations comprising an active agent, e.g. embedded in a pharmacologically acceptable biocompatible polymer or a lipid encapsulating agent, e.g. for periocular or subconjunctival administration.
    Type: Application
    Filed: August 20, 2008
    Publication date: December 11, 2008
    Inventors: Marklus Ahlheim, Michael Ausborn, David Bodmer, Christian Schoch
  • Pharmaceutical microparticles
    Publication number: 20080279955
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Application
    Filed: July 17, 2008
    Publication date: November 13, 2008
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Pharmaceutical compositions
    Publication number: 20070154520
    Abstract: A device implantable into a human or animal body comprising a biodegradable polymer which comprises ethylene carbonate units of the formula A —(—C(O)—O—CH2—CH2—O—)—??A having an ethylene carbonate content of 70 to 100 Mol %, an intrinsic viscosity of 0.4 to 4.0 dl/g measured in chloroform at 20° C. at a concentration of 1 g/dl and a glass transition temperature of from 5 to 50° C., degradable by surface erosion which is governed by a non-hydrolytic mechanism.
    Type: Application
    Filed: December 23, 2004
    Publication date: July 5, 2007
    Inventors: Michael Ausborn, Thomas Kissel
  • Organic compounds
    Publication number: 20070122485
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: January 8, 2007
    Publication date: May 31, 2007
    Inventors: Holger Petersen, Olivier Lambert, Rolf Loeffler, Michael Ausborn, Jean-Daniel Bonny
  • Microparticles prepared using an ionic liquid
    Publication number: 20060147532
    Abstract: Microparticles comprising at least one active agent embedded within a biocompatible, biodegradable polymeric matrix, wherein said microparticles are prepared with an ionic liquid.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 6, 2006
    Inventors: Michael Ausborn, Thomas Kissel, Ernst Kusters